Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Stanford University
Stanford University
British Columbia Cancer Agency
University of Southern California
Academic and Community Cancer Research United
Columbia University
Federation Francophone de Cancerologie Digestive
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center